Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
24 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/23/2951259/0/en/Ipsen-s-Kayfanda-odevixibat-approved-in-European-Union-for-cholestatic-pruritus-in-Alagille-Syndrome-a-rare-liver-disease.html
23 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/23/2951259/0/en/Ipsen-s-Kayfanda-odevixibat-approved-in-European-Union-for-cholestatic-pruritus-in-Alagille-Syndrome-a-rare-liver-disease.html
20 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/20/2949674/0/en/Ipsen-s-Iqirvo-elafibranor-approved-in-the-European-Union-as-first-new-treatment-for-primary-biliary-cholangitis-in-nearly-a-decade.html
19 Sep 2024
// EMA
https://www.ema.europa.eu/en/documents/overview/kayfanda-epar-medicine-overview_en.pdf
19 Sep 2024
// EMA
https://www.ema.europa.eu/en/documents/overview/iqirvo-epar-medicine-overview_en.pdf
17 Sep 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/despite-survival-miss-exelixis-presses-fda-prostate-cancer-filing-ipsen-scraps-eu-plan
ABOUT THIS PAGE
Ipsen is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Lanreotide Acetate bulk offered by Ipsen
Find a price of DYSPORT (BOTULINUM TOXIN TYPE A-HEMAGGLUTININ COMPLEX) bulk offered by Ipsen
LOOKING FOR A SUPPLIER?